In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
Health Catalyst Inc (NASDAQ: HCAT) closed the day trading at $5.60 down -7.13% from the previous closing price of $6.03. In other words, the price has decreased by -$7.13 from its previous closing price. On the day, 0.7 million shares were traded. HCAT stock price reached its highest trading level at $5.95 during the session, while it also had its lowest trading level at $5.55.
Ratios:
For a better understanding of HCAT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.39 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.68 whereas as Long-Term Debt/Eq ratio is at 0.67.
On January 03, 2024, Evercore ISI Upgraded its rating to Outperform which previously was In-line but kept the price unchanged to $11.
On January 03, 2024, Barclays started tracking the stock assigning a Overweight rating and target price of $14.Barclays initiated its Overweight rating on January 03, 2024, with a $14 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 15 ’24 when Llewelyn Linda sold 2,005 shares for $6.11 per share. The transaction valued at 12,251 led to the insider holds 126,226 shares of the business.
Llewelyn Linda sold 2,005 shares of HCAT for $15,648 on Mar 15 ’24. The Chief People Officer now owns 128,231 shares after completing the transaction at $7.80 per share. On Feb 27 ’24, another insider, Burton Daniel D., who serves as the Chief Executive Officer of the company, bought 26,200 shares for $7.81 each. As a result, the insider paid 204,525 and bolstered with 1,172,623 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HCAT now has a Market Capitalization of 353134880 and an Enterprise Value of 259292832. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.11 while its Price-to-Book (P/B) ratio in mrq is 0.89. Its current Enterprise Value per Revenue stands at 0.876 whereas that against EBITDA is -4.871.
Stock Price History:
Over the past 52 weeks, HCAT has reached a high of $14.37, while it has fallen to a 52-week low of $5.45. The 50-Day Moving Average of the stock is -26.19%, while the 200-Day Moving Average is calculated to be -40.30%.
Shares Statistics:
Over the past 3-months, HCAT traded about 624.77K shares per day on average, while over the past 10 days, HCAT traded about 615840 shares per day. A total of 58.30M shares are outstanding, with a floating share count of 55.71M. Insiders hold about 4.86% of the company’s shares, while institutions hold 87.15% stake in the company. Shares short for HCAT as of 1713139200 were 1758337 with a Short Ratio of 2.81, compared to 1710460800 on 1822781. Therefore, it implies a Short% of Shares Outstanding of 1758337 and a Short% of Float of 3.42.
